Study challenges concerns over short-term menopause hormone use in younger women, suggesting a reassessment of treatment practices based on safety findings.

Study reveals women nearing menopause have a 40% higher risk of depression, underscoring the importance of support and screening during this critical phase.

Addressing breast cancer treatment injustices entails overcoming social barriers and empowering patients for unrestricted healthcare decisions.